Skip Navigation
Skip to contents

JYMS : Journal of Yeungnam Medical Science

Indexed in: ESCI, Scopus, PubMed,
PubMed Central, CAS, DOAJ, KCI
FREE article processing charge


Page Path
HOME > J Yeungnam Med Sci > Volume 40(4); 2023 > Article
Case report
Septo-optic dysplasia associated with chromosome 15q13.3 duplication: a case report
Jeong A Ham1orcid, Sung Hyun Kim1orcid, Donghwi Park2orcid
Journal of Yeungnam Medical Science 2023;40(4):419-422.
Published online: December 2, 2022

1Department of Rehabilitation Medicine, DMC Bundang Jesaeng Hospital, Seoungnam, Korea

2Department of Physical Medicine and Rehabilitation, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Korea

Corresponding author: Sung Hyun Kim, MD Department of Rehabilitation Medicine, DMC Bundang Jesaeng Hospital, 20 Seohyeon-ro 180 beon-gil, Bundang-gu, Seoungnam 13590, Korea Tel: +82-31-779-0636 • Fax: +82-31-779-0635 • E-mail:
• Received: July 13, 2022   • Revised: August 24, 2022   • Accepted: October 13, 2022

Copyright © 2023 Yeungnam University College of Medicine, Yeungnam University Institute of Medical Science

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ( which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 67 Download
  • Septo-optic dysplasia (SOD) is a rare congenital anomaly that is clinically defined by developmental delay and characteristic brain magnetic resonance imaging findings, including optic nerve hypoplasia, pituitary hormone abnormalities, and midline brain defects. The occurrence of SOD is generally sporadic; however, it can be inherited rarely. Although an association with HESX1, SOX2, and SOX3 mutations has been identified, the detailed etiology is multifactorial and unclear. Here, we present the case of a 7-year-old girl who was clinically diagnosed with SOD and 15q13.3 duplication. Patients with duplication at chromosome 15q13.3 were reported to be diagnosed with autism spectrum disorder, epilepsy, and schizophrenia in previous studies. The relationship between SOD and the microduplication of 15q13.3 has not yet been explored. In this study, we suggest that there may be an association between chromosome 15q13.3 microduplication and SOD.
Septo-optic dysplasia (SOD) is a rare congenital developmental anomaly with a reported incidence of 1 in 10,000 live births. A diagnosis of SOD, also known as de Morsier syndrome, is mainly made clinically on the basis of the presence of two or more combinations of the following triad: (1) optic nerve hypoplasia, (2) midline brain defects such as the absence or hypoplasia of the septum pellucidum and corpus callosum, and (3) hypopituitarism [1].
The main clinical signs or symptoms of SOD include developmental delay, seizures, hearing or olfactory abnormalities, visual impairment, and pituitary dysfunction [2]. SOD generally occurs sporadically, but it can also be inherited, albeit rarely. HESX1 mutations are known to be related to familial cases, and recently, a link between SOX2 and SOX3 genes has also been identified [3]. However, the exact etiology is unclear and is thought to be multifactorial, including environmental and genetic factors.
Chromosome microarray analysis is a routine evaluation for many children with developmental delays; however, its utility in assessing SOD is unknown. We present the case of a 7-year-old girl with a clinical diagnosis of SOD and 15q13.3 duplication, and suggest possible associations between the two.
Ethical statements: This study was approved by the Institutional Review Board (IRB) of Ulsan University Hospital (IRB No: 2022-09-045). Written informed consent was obtained for publication of this case report and accompanying images.
A 7-year-old girl with congenital nystagmus and infantile esotropia presented to the ophthalmology outpatient department and was referred to us because of developmental delays. She was born at 37 weeks and 4 days of gestation via spontaneous vaginal delivery, and her birth weight was 2.77 kg. Her family and perinatal histories were unremarkable. The patient had no history of seizures. Her muscle tone was normal with brisk deep tendon reflexes, and overall muscle power was above good grade.
She fell frequently and exhibited an ataxic gait pattern. She had difficulty performing tandem gait and keeping up with her studies. Dysmorphic features, including a flat nasal bridge, an inverted upper lip, and slender epicanthal folds, were observed. At that time, she obtained a full scale intelligence quotient score of 53 on the Korean Wechsler Intelligence Scale for Children, 4th edition and social quotient score of 73.5 on the Social Maturity Scale.
Brain magnetic resonance imaging (MRI) showed absence of the septum pellucidum, hypoplasia of the optic tract and pituitary gland, partial thinning of the corpus callosum, and closed-lip schizencephaly in the left frontoparietal lobe (Fig. 1). SOD was clinically suspected and other differential tests were performed. There were no abnormal findings on an electroencephalogram. The absolute P100 latency was prolonged on the left side in the visual evoked potential test (P100=155 ms). Measurement of anterior pituitary hormones revealed low anti-thyroglobulin antibodies (<20 IU/mL), high thyroid-stimulating hormone (8 µIU/mL), and low cortisol (<1.0 µg/dL). Genetic testing was performed, and chromosome microarray analysis confirmed a 432-kb duplication on 15q13.3 (Fig. 2). The parents and other family members refused genetic testing for financial reasons.
Several studies have shown features related to chromosome 15q13.3 duplication. Patients with duplication at chromosome 15q13.3 have behavioral problems, dysmorphism, autism, mental retardation, and language delays [4]. Until recently, the reported diseases related to this chromosomal region included developmental delay, multiple congenital anomalies, epilepsy, schizophrenia, autism spectrum disorder, attention deficit hyperactivity disorder, major depressive disorder, Alzheimer disease, Parkinson disease, and congenital heart disease [5]. Microduplication of 15q13.3 involving CHRNA7 can disturb neuronal homeostasis by affecting nicotinic receptors in the brain. The alpha 7 nicotinic acetylcholine receptors are members of the ligand-gated ion channel family and are encoded by CHRNA7. These nicotinic receptors are found in the brain both pre- and postsynaptically, and are highly expressed in the hippocampus, cingulate gyrus, lateral geniculate nucleus, medial geniculate nucleus, and thalamus [6]. These receptors mediate synaptic signal transduction and regulate neurotransmitter release in the hippocampus and other brain regions [7]. The alpha 7 nicotinic receptors are also required for the development of normal local inhibitory neurocircuits and play an important role during the prenatal period [8]. However, it is still controversial whether microduplication in this chromosomal region is benign or pathological [9]. Because the 15q13.3 duplications have lower penetrance than other genomic diseases, the mutation is also observed in healthy controls and the phenotypes are variable; thus, disease association is difficult to determine [10].
SOD can be clinically suspected in children with developmental delay, seizures, strabismus or nystagmus, optic nerve hypoplasia, and insufficiency of cortisol, growth hormone, luteinizing hormone, follicle-stimulating hormone, and thyroid hormone. Typical brain MRI findings in SOD show absence of the septum pellucidum, optic nerve hypoplasia, schizencephaly, and structural abnormality of the pituitary gland. These findings imply an abnormality in the forebrain or anterior neural plate development [1,2].
HESX1, suggested to be a key gene in SOD, is a transcriptional repressor that plays an important role in early pituitary commitment and proliferation. In an animal model, a SOD phenotype was observed when HESX1 was mutated. SOX2 and SOX3 belong to the same SOXB1 family and are associated with developmental dysfunctions involving loss of DNA binding and transcriptional activation. SOX2 mutations can cause defects in the corpus callosum, eye disorders, hearing loss, short stature, and other congenital defects. Other genes have also been reported, including OTX2, PROKR2, FGF1, and FGF8 [2,3,11,12]. However, in practice, the causative gene for SOD has been identified in less than 1% of cases [2]. Moreover, it is difficult to determine a clear correlation.
The patient reported here had clinical symptoms and laboratory and brain MRI findings indicative of SOD. Chromosome microarray analysis revealed 15q13.3 microduplication. The relationship between SOD and microduplication of 15q13.3 has not been previously investigated, and there is no strong evidence for a causal relationship between them. However, although cases involving both SOD and duplication of 15q13.3 are rarely discovered, the two coexist in this case and have overlapping phenotypes.
In conclusion, we suggest a correlation between these two conditions. To the best of our knowledge, this is the first case report of SOD and chromosome 15q13.3 microduplication. Further studies on additional cases are needed to verify this association and determine how duplication contributes to SOD.

Conflicts of interest

No potential conflict of interest relevant to this article was reported.



Author contributions

Conceptualization, Data curation, Supervision: SHK, DP; Formal analysis: JAH, SHK; Methodology: JAH; Writing-original draft: JAH; Writing-review & editing: SHK, DP.

Fig. 1.
(A) Axial T2-weighted fluid-attenuated inversion recovery (FLAIR) image shows closed-lip schizencephaly in left frontoparietal lobe (arrow). (B) Axial T2-weighted FLAIR image shows abscence of the septum pellucidum (arrow). (C) Axial T2-weighted turbo spin echo shows hypoplasia of both optic nerves (arrows). (D) Sagittal T1-weighted FLAIR image shows partial thinning of genu of corpus callosum (arrowhead) and hypoplasia of the pituitary stalk and pituitary gland (arrow).
Fig. 2.
Chromosome microarray analysis detects duplication of a 432 kb on the chromosome 15q13.3 region.
  • 1. Ward DJ, Connolly DJ, Griffiths PD. Review of the MRI brain findings of septo-optic dysplasia. Clin Radiol 2021;76:160.e1-14.Article
  • 2. Webb EA, Dattani MT. Septo-optic dysplasia. Eur J Hum Genet 2010;18:393–7.ArticlePubMedPMCPDF
  • 3. Kelberman D, Dattani MT. Genetics of septo-optic dysplasia. Pituitary 2007;10:393–407.ArticlePubMedPDF
  • 4. Miller DT, Shen Y, Weiss LA, Korn J, Anselm I, Bridgemohan C, et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet 2009;46:242–8.ArticlePubMedPMC
  • 5. Lowther C, Costain G, Stavropoulos DJ, Melvin R, Silversides CK, Andrade DM, et al. Delineating the 15q13.3 microdeletion phenotype: a case series and comprehensive review of the literature. Genet Med 2015;17:149–57.ArticlePubMedPMCPDF
  • 6. Sinkus ML, Graw S, Freedman R, Ross RG, Lester HA, Leonard S. The human CHRNA7 and CHRFAM7A genes: a review of the genetics, regulation, and function. Neuropharmacology 2015;96(Pt B):274–88.ArticlePubMedPMC
  • 7. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev 2009;89:73–120.ArticlePubMedPMC
  • 8. Ross RG, Stevens KE, Proctor WR, Leonard S, Kisley MA, Hunter SK, et al. Research review: cholinergic mechanisms, early brain development, and risk for schizophrenia. J Child Psychol Psychiatry 2010;51:535–49.ArticlePubMedPMC
  • 9. Szafranski P, Schaaf CP, Person RE, Gibson IB, Xia Z, Mahadevan S, et al. Structures and molecular mechanisms for common 15q13.3 microduplications involving CHRNA7: benign or pathological? Hum Mutat 2010;31:840–50.ArticlePubMedPMC
  • 10. Xie Y. Is chromosome 15q13.3 duplication involving CHRNA7 associated with oral clefts? Child Neurol Open 2015;2:2329048X15618918.ArticlePubMedPMCPDF
  • 11. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Mårtensson IL, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125–33.ArticlePubMedPDF
  • 12. Hagstrom SA, Pauer GJ, Reid J, Simpson E, Crowe S, Maumenee IH, et al. SOX2 mutation causes anophthalmia, hearing loss, and brain anomalies. Am J Med Genet A 2005;138A:95–8.ArticlePubMed

Figure & Data



    Citations to this article as recorded by  


      JYMS : Journal of Yeungnam Medical Science